Pricing Log in Create free account
Sunday 8 November 2026 Export PFE’s income statement to Excel — free account

Pfizer Inc.

PFE

Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.

Revenue
−0.43%
EPS
−7.98%
Free cash flow
+20.0%
Total debt
+1.55%

Quarter to September 2026, against a year earlier

29.39 0.49 −1.64%
Market cap
$170.3B
P/E
41.3×
Fwd P/E
17.7×
Dividend yield
5.87%
F-score
6/9
ROIC
6.19%
Net debt / EBITDA
2.5×
Dividend safety
28/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Pfizer Inc. (PFE) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Pfizer Inc. (PFE) trades at a EV/Sales of 3.4×. Over the past ten years it has ranged from 2.3× (March 2023) to 8.7× (December 2020); the current reading is higher than 31% of that period. That is below the Drug Manufacturers General industry median of 4.1× and in line with the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.1× 0.92%
FY2024 3.1× (19.94%)
FY2023 3.8× 28.29%
FY2022 3.0× (28.58%)
FY2021 4.2× (25.36%)
FY2020 5.6× (10.89%)
FY2019 6.3× (6.64%)
FY2018 6.7× 49.05%
FY2017 4.5× 7.58%
FY2016 4.2× (0.35%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.3× 11.91%
Jun 2026 3.0× (11.17%)
Mar 2026 3.3× 8.31%
Dec 2025 3.1× 0.92%
43 more quarters

Against its own ten years

Low 2.3× High 8.7×
Ten-year median 4.2×
Current reading's percentile 33

EV/Sales against peers

Company EV/Sales
SNY Sanofi compare 2.1×
GSK GSK PLC Sponsored ADR compare 2.9×
BMY Bristol Myers Squibb Company compare 3.1×
PFE Pfizer Inc. 3.4×
NVO Novo Nordisk A/S compare 3.7×
AZN AstraZeneca PLC compare 5.0×
NVS Novartis AG compare 6.0×
GILD Gilead Sciences, Inc. compare 7.3×
AMGN Amgen Inc. compare 7.5×
Drug Manufacturers General industry median 4.1×
Healthcare sector median 3.6×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PFE